Racial and ethnic disparities in polysubstance overdose deaths are widening, particularly among Black and Hispanic men, while treatment guidelines lag and no FDA-approved therapies exist for stimulant use disorder. @CUEpidemiology
https://t.co/m2dLhKaoZ7
Had a fantastic time reconnecting with colleagues and meeting future collaborators at #SAVIR2025! Honored to receive the Best Poster Award for our work showing rising drug poisoning mortality among Black men and women. Grateful to share our findings: https://t.co/I7Eg09csSq
Thrilled to receive the Health Disparities Research LRP award from @NIH_LRP @NIDA! Huge thanks to my incredible mentors @ssm2183@drdustinduncan@renee_m_johnson Sabriya & Pia.
Friends, I'm here if you want to chat about the LRP application process.#NIHLRP#DiversityAndInclusion
Today, ASAM & other stakeholders asked the @US_FDA to retract its Jan. 12th safety communication regarding buprenorphine: https://t.co/IPzPIXyIWR. Here’s why (THREAD 🧵): @SAMHSAGov
We're all connected. Your freedom not to wear a mask indoors in a public place where Covid is spreading isn't more important than someone else’s freedom to live.